[Federal Register Volume 68, Number 174 (Tuesday, September 9, 2003)]
[Notices]
[Page 53180]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-22816]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the National Cancer Institute Director's Consumer Liaison Group.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: National Cancer Institute Director's Consumer 
Liaison Group.
    Date: September 24, 2003.
    Time: 8 a.m. to 5 p.m.
    Agenda: Open; Future of DCLG Process; Results of Advocacy 
Survey; Recommendations for Future of DCLG; Role on Behalf of 
Advocacy Community; Advocates on Other NCI Advisory Committees; 
Priority Issues; President's Cancer Panel Model; Function Regarding 
NCI Priorities; Role of Consumer in Research and Related Activities 
Program; Membership; Communication/Involvement with Advocacy 
Community; Summary & Next Steps.
    Place: Double Tree Rockville, 1750 Rockville Pike, Rockville, MD 
20852.
    Contact Person: Nancy Caliman, Executive Secretary, Office of 
Liaison Activities, National Institutes of Health, National Cancer 
Institute, 6116 Executive Boulevard, Suite 220, MSC 8324, Bethesda, 
MD 20892, (301) 496-0307, [email protected].
    Information is also available on the Institute's/Center's home 
page: deainfo.nci.nih.gov/advisory/dclg/dclg.htm, where an agenda 
and any additional information for the meeting will be posted when 
available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support, 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: August 26, 2003.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 03-22816 Filed 9-8-03; 8:45 am]
BILLING CODE 4140-01-M